DigiPath, Inc. Reports Earnings Results for the Full Year Ended September 30, 2020
January 29, 2021 at 06:13 am
Share
DigiPath, Inc. announced earnings results for the full year ended September 30, 2020. For the full year, the company announced sales was USD 2.574 million compared to USD 2.552 million a year ago. Operating loss was USD 2.192 million compared to USD 1.843 million a year ago. Net loss was USD 2.309 million compared to USD 1.805 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 0.04 a year ago.
Hypha Labs, Inc., formerly Digipath, Inc., has developed technology that cultivates the mycelium root structures of psilocybin mushrooms and other functional mushroom's mycelium into a natural product. This product has an exact, consistent potency containing all the natural compounds found in these fungi. Typically, it takes six-eight weeks to fully grow mushrooms, and using its technology, the production of the active ingredient is only seven-10 days. This natural product solves the dosing issue created by having to use whole mushrooms. The product is tasteless and gentler on the stomach and can be used sublingually for fast-acting results. The product allows the consumer to produce measurable active ingredients at home for mental and physical benefits. It provides Psilocybin Mushrooms, Button Mushrooms, Shiitake Mushrooms, Maitake Mushrooms, Reishi Mushrooms, Lion's Mane Mushrooms, Oyster Mushrooms, Oyster Mushrooms and Crimini Mushrooms.
HYPHA LABS, INC. 
